<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04871425</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00012218</org_study_id>
    <nct_id>NCT04871425</nct_id>
  </id_info>
  <brief_title>Ketamine Versus Fentanyl for Surgical Abortions</brief_title>
  <official_title>Ketamine Versus Fentanyl for Surgical Abortions: A Randomized Controlled Noninferiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Society of Family Planning</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ketamine is commonly used for procedural sedation and analgesia. It is widely used for trauma&#xD;
      cases in the emergency department and is considered a superior agent in the outpatient&#xD;
      setting due to its lack of respiratory and cardiovascular depression. In chronic opioid&#xD;
      users, ketamine decreases acute pain and reduces postoperative opioid consumption. Few&#xD;
      studies have examined the use of ketamine for surgical abortions. Previous studies found&#xD;
      significant rates of emergence phenomena; however, this can be prevented if a benzodiazepine&#xD;
      is given at the same time. Ketamine deserves further study to determine whether it is an&#xD;
      acceptable alternative to a standard opioid-based regimen for surgical abortion. Our primary&#xD;
      objective is to compare patient satisfaction after surgical abortion among patients receiving&#xD;
      IV ketamine versus IV fentanyl for procedural sedation. Our secondary objectives include&#xD;
      postoperative pain, additional pain medication used, and postoperative opioid use after the&#xD;
      procedure. Our hypothesis is that ketamine will provide similar patient satisfaction and&#xD;
      reduce postoperative opioid use. This will be a randomized controlled noninferiority clinical&#xD;
      trial of 84 women receiving either IV ketamine with IV midazolam or IV fentanyl with IV&#xD;
      midazolam for outpatient one day surgical abortions up to 13, 6/7 weeks gestation. Both&#xD;
      groups will receive a standardized paracervical block and additional pain medication as&#xD;
      needed. Our study has the potential to introduce IV ketamine as a satisfactory medication for&#xD;
      outpatient surgical abortions. Ketamine may decrease the need for IV fentanyl, reduce&#xD;
      postoperative opioid use, and may prove to be a superior analgesic for chronic opioid users.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction with anesthesia assessed by the ISAS</measure>
    <time_frame>At discharge or 30 minutes after the procedure</time_frame>
    <description>After the procedure, either at time of discharge (if less than 30 minutes) or at 30 minutes (if not yet discharged), research personnel will assess the participant's satisfaction with anesthesia using the Iowa Satisfaction with Anesthesia Scale. This is a validated perioperative anesthesia satisfaction scale with a minimum score of -3 and a maximum score of +3 with higher scores indicating higher satisfaction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Provider satisfaction with anesthesia assessed by the VAS</measure>
    <time_frame>Immediately postoperatively</time_frame>
    <description>After the procedure, research personnel will assess provider's satisfaction with patient's anesthesia on a 100mm visual analog scale. The minimum score is 0mm and the maximum score if 100mm, with higher scores indicating higher satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional pain medications necessary</measure>
    <time_frame>Immediately postoperatively</time_frame>
    <description>After the procedure, research personnel will ask anesthetist what medications, if any, they gave outside of the study protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain assessed by the VAS</measure>
    <time_frame>24 hours postoperatively and 7 days postoperatively</time_frame>
    <description>Patients will complete 2 followup surveys asking about their postoperative pain after discharge. This will be assessed on a 100mm visual analog scale. The minimum score is 0mm and the maximum score if 100mm, with higher scores indicating higher pain levels.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Abortion in First Trimester</condition>
  <condition>Pain, Procedural</condition>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant will receive 2mg IV midazolam and 0.2-0.5mg/kg IV ketamine over 2 minutes, which can be repeated q5 minutes until appropriate analgesia is achieved.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participant will receive 2mg IV midazolam and 0.5-1mcg/kg IV fentanyl over 2 minutes, which can be repeated q5m until appropriate analgesia is achieved.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>IV ketamine</description>
    <arm_group_label>Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>IV fentanyl</description>
    <arm_group_label>Fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 14 years or older&#xD;
&#xD;
          -  Voluntarily requesting surgical pregnancy termination&#xD;
&#xD;
          -  Intrauterine pregnancy up to 13 weeks 6 days by transabdominal or transvaginal&#xD;
             ultrasound performed on day of procedure&#xD;
&#xD;
          -  Eligible for suction curettage&#xD;
&#xD;
          -  English or Spanish speaking&#xD;
&#xD;
          -  Able and willing to give informed consent and agree to terms of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 14 years&#xD;
&#xD;
          -  Reaspiration procedure or failed medication abortion&#xD;
&#xD;
          -  Early pregnancy loss&#xD;
&#xD;
          -  Alcohol use disorder or acute alcohol intoxication&#xD;
&#xD;
          -  Currently incarcerated&#xD;
&#xD;
          -  Gestational age 14 weeks or more&#xD;
&#xD;
          -  Requesting a specific pain regimen&#xD;
&#xD;
          -  Premedication with misoprostol&#xD;
&#xD;
          -  Contraindications or allergies to ketamine or fentanyl&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Chin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fellow</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Chin, MD</last_name>
    <phone>206-221-9074</phone>
    <email>jmyc@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erin McCoy, MPH</last_name>
    <phone>206-221-8105</phone>
    <email>eemccoy@uw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cedar River Clinic</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedar River</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Jennifer Chin</investigator_full_name>
    <investigator_title>Fellow, Family Planning: School of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Procedural</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

